Stand Up To Cancer announces gastric cancer interception research team

(Stand Up To Cancer) A new SU2C team to intercept gastric cancer, led by Andrew T. Chan, MD, MPH, (Harvard Medical School) and Sandra Ryeom, PhD, (University of Pennsylvania) with researchers from University of Chicago, City of Hope, Memorial Sloan Kettering Cancer Center and Samsung Medical Center (Seoul, Korea) will receive $3MM team to seek biomarkers, such DNA and cells shed from the tumor circulating in the blood system, indicating the presence of gastric cancer.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news